Some people think we will see an immediate dip after uplisting due to aggressive shorting. I seriously doubt this myself. Shorts want to maximize their chances just like longs. Instead, I believe that we will see a major surge of buying due to international buyers with new access to buy shares, and also due to the ability for retailers like us to buy more/double down on margin. So short sellers will wait for this to occur first, and then they will have a great chance to capitalize, starting when we get up to, say, $15 a share. Then maybe the volatility starts.
In addition to margin, uplisting to the Nasdaq allows shares to be bought around the world in their brokerage accounts (unlike OTC),
Hmmm, I wonder how many people in Australia ALONE might try to by AVXL stock??? Remember, Anavex has generated a lot more publicity outside the U.S. And there are now limited shares available after reverse split. It's a set-up for a price explosion.
FOMO (fear of missing out) is a MAJOR issue with AVXL. If they present convincing positive early Part B data at the conference, Anavex is a legitimate buyout target-- hostile or otherwise. Maybe even a bidding war. And soon. So those who sell the pop take their chances in being out of the stock.
I agree. There will NOT be bad news on 11/7. A 1:4 reverse split with uplisting before bad news would be suicide. That being said, if the results are only "promising"-- not the blockbuster announcement that many are hoping for-- it could possibly disappoint investors. So we might not get the huge pop (or drop either for that matter.)
That's not really the jist of what I meant. We need to have a trial-proven product that has potential to make $$$ in the marketplace and which makes Idera attractive to acquire at any point in the future.
Jr... It has definitely been frustrating. But, as I've said many times before, Idera won't soar until we are a legitimate buyout target. We likely must have a solid phase 2 behind us (going into phase 3) with a product that somebody will covet. Putting it another way, once we are a buyout candidate, people can't afford to take the chance of being OUT of the stock.
Also notice that CNCE has a low float, lots of institutional money (including Baker Bros), and has not gone down at all during this severe biotech correction. It all points to a rocket ship launch soon.
Yes, I have another. Keep an eye on CNCE. If Anavex shows positive results with their sigma-1 agonist drug-- and becomes a buyout target-- so will CNCE. They have a sigma-1 agonist drug in their pipeline (early). So if this mechanism turns out to be the real deal. Anavex gets bought out first and then everyone will want CNCE. Additionally, they have a deep pipeline and lots of shots on goal.
Nah-- I just got lucky on that one (so far). I do have another pick though. It's called Idera (symbol IDRA). Maybe a 15% downside risk at most and 1000% upside potential over the next year.
You're welcome, but as they say, you don't make a dime until you sell. And Anavex will soon will have somewhat of a major binary event. Somewhat de-risked by known earlier data and by it being announced earlier than necessary, but still very risky nonetheless.
It's mind blowing to realize what Anavex 2-73 could be worth if (and that's a BIG if) it works on a multitude of CNS diseases. Share price in the $100's.
Hey Ctixers-- we will go way past $10 this week. That's only a $0.50 gain equivalent in pre-split shares. There will be no downside pressure this week, as it's too early for a short attack (too many people still want in, and then there's also the looming new buys after uplisting).
Yes, massive buying when we uplist. Every guy here in their Scottrade, Schwab, or Ameritrade margin account etc will see that they suddenly can buy thousands of shares on margin. Temptation!!!
Also, how many folks in Australia alone will buy Anavex when it becomes available on their exchange for the first time?
Folks, we are going parabolic well before results...
The day it gets listed on Nasdaq it will be easily available to buy all over the world. And it will also be eligible to buy on margin (on Nasdaq, and greater than $3), so many of us can double down if we want. And all of this with few shares available. This will get explosive long before Nov. 7th
Today is the first full day that all stock has been unlocked at all brokerages, but few retailers have sold to lock in profits. I figure shorts now have to cover soon, and there is a lot of blue sky ahead!
Tough call. Only sell half IDRA at most, and only buy AVXL on dip. And then sell half of AVXL for profit on a run-up before results. Only hold half through results.